Vaughan Nelson Investment Management L.P. Sells 84,960 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Vaughan Nelson Investment Management L.P. lowered its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 10.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 758,463 shares of the company's stock after selling 84,960 shares during the period. Vaughan Nelson Investment Management L.P. owned approximately 0.88% of HealthEquity worth $72,774,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Paladin Wealth LLC acquired a new position in shares of HealthEquity in the third quarter valued at approximately $39,000. UMB Bank n.a. increased its position in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after acquiring an additional 164 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock valued at $77,000 after acquiring an additional 344 shares during the period. Quarry LP lifted its holdings in shares of HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock valued at $110,000 after acquiring an additional 1,089 shares in the last quarter. Finally, 1620 Investment Advisors Inc. purchased a new stake in HealthEquity during the 3rd quarter worth $112,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have commented on HQY. Barrington Research boosted their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research note on Monday, December 2nd. BTIG Research boosted their price target on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. JMP Securities upped their price target on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. Royal Bank of Canada lifted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. Finally, The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a "neutral" rating and a $108.00 target price for the company. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $110.71.

Insiders Place Their Bets

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company's stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,000 shares of company stock valued at $3,895,788 over the last quarter. Insiders own 2.20% of the company's stock.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $2.01 during trading on Wednesday, reaching $114.51. The stock had a trading volume of 1,247,283 shares, compared to its average volume of 764,914. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market cap of $9.92 billion, a PE ratio of 105.06, a P/E/G ratio of 1.61 and a beta of 0.55. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $114.69. The firm's 50 day moving average price is $101.63 and its two-hundred day moving average price is $90.37.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the business posted $0.40 EPS. On average, research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.